Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority)PARIS, May06, 2024(GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595DateTotal number of shares in the capitalTotal number of voting rights 04/30/202471,955,53577,891,229 For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,[email protected] Patricia...
New York,
(informazione.it - comunicati stampa - salute e benessere)
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, May 06, 2024 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital |
Total number of voting rights |
| 04/30/2024 | 71,955,535 | 77,891,229 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, [email protected]
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93, [email protected]
Investor Relations contacts:
Arthur Stril, Chief Financial Officer (interim), +1 (347) 809 5980, [email protected]
Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577
Attachment
Per maggiori informazioni
Sito Web
cellectis.com
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
